DailyDoctor Archive Specialties Get app
Back to the 28 October 2026 edition

Research · 02 of 05

Squamous cell carcinoma keeps rising in England, and so does skin cancer mortality

Keep a low threshold for examining and biopsying keratotic lesions in very old patients, where squamous cell carcinoma is still increasing.

Design
National registry analysis with joinpoint regression
Population
All keratinocyte cancers diagnosed in England, 2013 to 2022
Primary outcome
Age-standardised incidence and mortality trends
Effect
2022 cSCC 102 per 100,000; NMSC mortality APC 4.0% (2.5 to 5.7)

This registry study analysed every keratinocyte cancer diagnosed in England from 2013 to 2022, counting up to one basal cell and one squamous cell carcinoma per person per year. That method found 67% more basal cell and 42% more squamous cell carcinomas than counting only each person's first tumour.

In 2022 the age-standardised rates were 295 per 100,000 person-years for basal cell carcinoma and 102 for cutaneous squamous cell carcinoma. Basal cell carcinoma rates have been flat since 2015 (annual change −0.2%, 95% CI −0.8 to 0.3). Squamous cell carcinoma rose 6.1% a year to 2015 and 2.3% a year to 2019, and kept rising in people under 60 and over 80. Non-melanoma skin cancer mortality rose 4.0% a year (2.5 to 5.7), faster in men than in women.

The numbers are English and from a mostly White population, so they do not transfer directly to Indian practice, where keratinocyte cancer is far less common. The message that travels is about the oldest patients: squamous cell carcinoma in people over 80 is increasing, and these are the patients least able to reach a clinic quickly.

  • Examine the skin of patients over 80 at routine visits, since squamous cell carcinoma is still rising in that group.
  • Do not assume squamous cell carcinoma is confined to the elderly; rates are also rising under 60.
  • Prioritise fast assessment for a rapidly growing or tender keratotic lesion.
  • Count every tumour, not just the first, if your service audits its skin cancer workload.

Why it matters

Rising mortality from a mostly curable cancer points to late presentation, especially in the very old.

The statistics, in plain English

An annual percentage change of 4.0% in mortality compounds to roughly a 40% rise over the decade. The interval for basal cell carcinoma spans zero, meaning its rate has effectively stopped changing.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

psoriasisskincancerimmunobullous

Tomorrow morning, before your first patient

One edition a day for dermatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app